Application of Tc-99m-tetrofosmin as a tumor imaging agent: comparison with Tl-201

Ann Nucl Med. 1996 May;10(2):271-4. doi: 10.1007/BF03165405.

Abstract

Tc-99m-tetrofosmin SPECT was performed on 6 occasions in 4 patients with hypopharyngeal carcinoma, lung carcinoma, esophageal carcinoma and maxillary plasmocytoma and compared with Tl-201 SPECT. All lesions accumulated both Tc-99m-tetrofosmin and Tl-201. Early uptake ratios of Tc-99m-tetrofosmin were about 2 but those of Tl-201 were much higher (more than 3). Washout rates of Tc-99m-tetrofosmin were higher than those of Tl-201. There was a good positive correlation between the early uptake ratio of Tc-99m-tetrofosmin and that of Tl-201. The delayed uptake ratio and washout rate showed poor correlation. In conclusion, early uptakes of both the agents were similar but their retention patterns were different. Tc-99m-tetrofosmin may be used for tumor imaging though more studies are required to evaluate diagnostic accuracy and the significance of delayed images.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Esophageal Neoplasms / diagnostic imaging
  • Esophageal Neoplasms / pathology
  • Female
  • Humans
  • Hypopharyngeal Neoplasms / diagnostic imaging
  • Lung Neoplasms / diagnostic imaging
  • Lymphatic Metastasis
  • Male
  • Maxillary Sinus Neoplasms / diagnostic imaging
  • Metabolic Clearance Rate
  • Middle Aged
  • Neoplasms / diagnostic imaging*
  • Organophosphorus Compounds* / pharmacokinetics
  • Organotechnetium Compounds* / pharmacokinetics
  • Plasmacytoma / diagnostic imaging
  • Thallium Radioisotopes* / pharmacokinetics
  • Tomography, Emission-Computed, Single-Photon / methods*

Substances

  • Organophosphorus Compounds
  • Organotechnetium Compounds
  • Thallium Radioisotopes
  • technetium tc-99m tetrofosmin